|
Phase I, open-label study of pasireotide in patients with BRAF-wild type and NRAS-wild type, unresectable and/or metastatic melanoma |
|
|
|
Titel: |
Phase I, open-label study of pasireotide in patients with BRAF-wild type and NRAS-wild type, unresectable and/or metastatic melanoma |
Auteur: |
Dummer, Reinhard Michielin, Olivier Nägeli, Mirjam Chantal Goldinger, Simone M. Campigotto, Federico Kriemler-Krahn, Ulrike Schmid, Herbert Pedroncelli, Alberto Micaletto, Sara Schadendorf, Dirk |
Verschenen in: |
ESMO open |
Paginering: |
Jaargang 3 () nr. 5 pagina's p. |
Jaar: |
2018 |
Inhoud: |
|
Uitgever: |
© 2018 THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|